As of November 2024, Samjin Pharmaceuticals has a market cap of $174.69M. This makes Samjin Pharmaceuticals the world's 18167th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $199.35M | -4.17% |
2023 | $208.02M | -15.79% |
2022 | $247.02M | -2.47% |
2021 | $253.28M | -3.49% |
2020 | $262.43M | 9.22% |
2019 | $240.28M | -37.86% |
2018 | $386.66M | 11.99% |
2017 | $345.25M | 3.17% |
2016 | $334.65M | 49.46% |
2015 | $223.91M | 8.64% |
2014 | $206.09M | 48.10% |
2013 | $139.16M | 35.68% |
2012 | $102.56M | 33.96% |
2011 | $76.56M | -30.26% |
2010 | $109.79M | -5.58% |
2009 | $116.27M | 44.65% |
2008 | $80.38M | -24.57% |
2007 | $106.56M | 25.77% |
2006 | $84.73M | -5.93% |
2005 | $90.07M | - |